Targeted delivery of CD40L promotes restricted activation of antigen-presenting cells and induction of cancer cell death

BACKGROUND: Stimulation of CD40 can augment anti-cancer T cell immune responses by triggering effective activation and maturation of antigen-presenting cells (APCs). Although CD40 agonists have clinical activity in humans, the associated systemic activation of the immune system triggers dose-limitin...

Descripción completa

Detalles Bibliográficos
Autores principales: Brunekreeft, Kim L, Strohm, Corinna, Gooden, Marloes J, Rybczynska, Anna A, Nijman, Hans W, Grigoleit, Götz U, Helfrich, Wijnand, Bremer, Edwin, Siegmund, Daniela, Wajant, Harald, de Bruyn, Marco
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4022212/
https://www.ncbi.nlm.nih.gov/pubmed/24741998
http://dx.doi.org/10.1186/1476-4598-13-85

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4022212/
https://www.ncbi.nlm.nih.gov/pubmed/24741998
http://dx.doi.org/10.1186/1476-4598-13-85

Ejemplares similares